Secondary prevention of coronary heart disease in primary care is cost effective.
作者信息
McKnight A, Cupples M
出版信息
BMJ. 1996 Aug 31;313(7056):563. doi: 10.1136/bmj.313.7056.563.
Abstract
摘要
相似文献
1
Secondary prevention of coronary heart disease in primary care is cost effective.初级保健中冠心病的二级预防具有成本效益。
BMJ. 1996 Aug 31;313(7056):563. doi: 10.1136/bmj.313.7056.563.
2
An action plan for preventing coronary heart disease in primary care. Working Group of the Coronary Prevention Group and the British Heart Foundation.基层医疗中预防冠心病的行动计划。冠心病预防小组及英国心脏基金会工作组
BMJ. 1991 Sep 28;303(6805):748-50. doi: 10.1136/bmj.303.6805.748.
3
Contemporary management of coronary heart disease.冠心病的当代管理
J R Coll Physicians Edinb. 2010 Mar;40(1):44-7; quiz 48. doi: 10.4997/JRCPE.2010.122.
4
Health promotion for coronary heart disease: past, present and future.冠心病的健康促进：过去、现在与未来。
Eur Heart J. 1998 Dec;19(12):1751-7. doi: 10.1053/euhj.1998.1207.
5
Assessment of the impact of fibrates and diet on survival and their cost-effectiveness: evidence from randomized, controlled trials in coronary heart disease and health economic evaluations.贝特类药物和饮食对生存率的影响及其成本效益评估：来自冠心病随机对照试验和健康经济评估的证据。
Clin Ther. 1999 Nov;21(11):2027-35. doi: 10.1016/S0149-2918(00)86748-X.
6
Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial.向患者及全科医生发送邮政提示对冠心病事件后初级保健质量的影响（POST）：随机对照试验
BMJ. 1999 Jun 5;318(7197):1522-6. doi: 10.1136/bmj.318.7197.1522.
7
The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease.英国国民医疗服务体系：在冠心病全谱系中提供公平治疗。
Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):208-16. doi: 10.1161/CIRCOUTCOMES.111.000058. Epub 2013 Mar 12.
8
Effects of secondary prevention clinics on health status in patients with coronary heart disease: 4 year follow-up of a randomized trial in primary care.二级预防诊所对冠心病患者健康状况的影响：一项初级保健随机试验的4年随访
Fam Pract. 2004 Oct;21(5):567-74. doi: 10.1093/fampra/cmh514.
9
An economic evaluation of fluvastatin used for the prevention of cardiac events following successful first percutaneous coronary intervention in the UK.氟伐他汀用于预防英国首次经皮冠状动脉介入治疗成功后心脏事件的经济学评估。
Pharmacoeconomics. 2004;22(8):525-35. doi: 10.2165/00019053-200422080-00004.
10
National smoking cessation services at risk.国家戒烟服务面临风险。
BMJ. 2001 Nov 17;323(7322):1140-1. doi: 10.1136/bmj.323.7322.1140.
本文引用的文献
1
Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study.心血管筛查与干预的成本及成本效益：英国家庭心脏研究
BMJ. 1996 May 18;312(7041):1269-73. doi: 10.1136/bmj.312.7041.1269.
2
Costs and cost effectiveness of health checks conducted by nurses in primary care: the Oxcheck study.初级保健中护士进行健康检查的成本及成本效益：Oxcheck研究
BMJ. 1996 May 18;312(7041):1265-8. doi: 10.1136/bmj.312.7041.1265.
3
Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk.针对心血管高危患者在全科医疗中开展健康促进的随机对照试验。
BMJ. 1994 Oct 15;309(6960):993-6. doi: 10.1136/bmj.309.6960.993.
Zotero 插件